(19)
(11) EP 4 351 544 A1

(12)

(43) Date of publication:
17.04.2024 Bulletin 2024/16

(21) Application number: 22738724.8

(22) Date of filing: 08.06.2022
(51) International Patent Classification (IPC): 
A61K 31/05(2006.01)
A61K 9/06(2006.01)
A61P 17/02(2006.01)
A61P 17/06(2006.01)
 A61K 31/575(2006.01)
A61P 17/00(2006.01)
A61P 17/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/05; A61K 31/575; A61K 9/06; A61P 17/04; A61P 17/00; A61P 17/02; A61P 17/06; A61K 9/0014
 
C-Sets:
  1. A61K 31/05, A61K 2300/00;
  2. A61K 31/575, A61K 2300/00;
(86) International application number:
PCT/IB2022/055341
(87) International publication number:
WO 2022/259179 (15.12.2022 Gazette 2022/50)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.06.2021 IT 202100014966

(71) Applicants:
  • S&R Farmaceutici S.p.A.
    06083 Bastia Umbra (IT)
  • G&C Biotech S.r.l.
    06083 Bastia Umbra (PG) (IT)

(72) Inventors:
  • FIORETTI, Bernard
    06034 Foligno (PG) (IT)
  • CLERICI, Carlo
    06034 Foligno (PG) (IT)
  • CLERICI, Graziano
    06035 Gualdo Cattaneo (PG) (IT)
  • CRUCIANI, Gabriele
    06135 Perugia (IT)
  • LEONARDI, Lucio
    06035 Gualdo Cattaneo (PG) (IT)

(74) Representative: Benedetto, Marco 
Marben S.r.l. Via Larga, 16
20122 Milano
20122 Milano (IT)

   


(54) USE OF STOICHIOMETRIC COMBINATION OF RESVERATROL AND BILE ACIDS FOR TOPICAL TREATMENT OF NEUROGENIC INFLAMMATION AND ITCHING